Changes in the Gene Expression of GABAA Receptor α1 and α2 Subunits and Metabotropic Glutamate Receptor 5 in the Basal Ganglia of the Rats with Unilateral 6-Hydroxydopamine Lesion and Embryonic Mesencephalic Grafts-Reference-Cited by-同舟云学术

Changes in the Gene Expression of GABAA Receptor α1 and α2 Subunits and Metabotropic Glutamate Receptor 5 in the Basal Ganglia of the Rats with Unilateral 6-Hydroxydopamine Lesion and Embryonic Mesencephalic Grafts

Published:2001-04 Issue:2 Volume:168 Page:231-241
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Yu Tzong-Shiue,Wang Shwun-De,Liu Jiang-Chuan,Yin Hsiang-Shu

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference42 articles.

1. International union of pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: Classification on the basis of subunit structure and receptor function;Barnard;Pharmacol. Rev.,1998

2. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus;Bergman;Science.,1990

3. Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion;Bernard;J. Comp. Neurol.,1996

4. Glutamate and Parkinson's disease;Blandini;Mol. Neurobiol.,1996

5. Survival, growth and function of dopaminergic neurons grafted to the brain;Brundin;Prog. Brain Res.,1987

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The α1 and γ2 subunit-containing GABAA receptor-mediated inhibitory transmission in the anteroventral bed nucleus of stria terminalis is involved in the regulation of anxiety in rats with substantia nigra lesions;Neuropharmacology;2023-10

2. Cystic fibrosis transmembrane conductance regulator-associated ligand protects dopaminergic neurons by differentially regulating metabotropic glutamate receptor 5 in the progression of neurotoxin 6-hydroxydopamine-induced Parkinson's disease model;NeuroToxicology;2021-05

3. PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson’s Disease;Neurotherapeutics;2019-05-09

4. Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus;Glia;2017-08-24

5. Involvement of lateral habenula α1 subunit-containing GABA A receptor-mediated inhibitory transmission in the regulation of depression-related behaviors in experimental Parkinson's disease;Neuropharmacology;2017-04